PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs SUPN |
|---|---|---|---|---|---|
| INVA | Innoviva, Inc. | 0.41 | 5.2 | 12.7% | — |
| COLL | Collegium Pharmaceutical, Inc. | 1.46 | 29.9 | 20.5% | — |
| PAHC | Phibro Animal Health Corporation | 1.77 | 13.2 | 7.5% | — |
| PBH | Prestige Consumer Healthcare Inc. | 6.64 | 24.5 | 3.7% | — |
| CORT | Corcept Therapeutics Incorporated | 333.61 | 214.8 | 0.6% | — |